NFKB1 Antikörper (Nuclear Factor of kappa Light Polypeptide Gene Enhancer in B-Cells 1) (HRP)

Produktnummer ABIN1958181

Produktdetails anti-NFKB1 Antikörper

Target:

NFKB1

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser NFKB1 Antikörper ist konjugiert mit HRP

Applikation: Chromatin Immunoprecipitation (ChIP), ELISA, Immunohistochemistry (IHC), Western Blotting (WB)

Spezifität: Human NFKB1

Aufreinigung: Caprylic acid and ammonium sulfate precipitation

Immunogen: Recombinant human Nuclear factor NF-kappa-B p105 subunit protein.

Type of Immunogen: Recombinant protein

Isotyp: IgG

Details zu NFKB1

Target:

NFKB1

Andere Bezeichnung: NFKB1 (NFKB1 Antibody Abstract)

Hintergrund: Name/Gene ID: NFKB1
Family: Apoptosis

Synonyms: NFKB1, Ebp- 1, EBP-1, NF-KappaB p50, NFkappaB, NFKB-p50, KBF1, NF-kappa-B, NF-kappaB, NF-kB1, NFKB-p105, p105, p50, DNA binding factor KBF1, DNA-binding factor KBF1, NF-kappabeta

Gen-ID: 4790

Pathways: p53 Signalweg, NF-kappaB Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, TLR Signalweg, Fc-epsilon Rezeptor Signalübertragung, Neurotrophin Signalübertragung, Activation of Innate immune Response, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Toll-Like Receptors Cascades

Anwendungsinformationen

Applikationshinweise: Approved: ChrIP, ELISA, IHC, WB

Usage: The applications listed have been tested for the unconjugated form of this product. Other forms have not been tested.

Kommentare:

Target Species of Antibody: Human

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: Lot specific

Buffer: PBS,  pH 7.4, 0.03 % Proclin 300, 50 % glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Avoid freeze-thaw cycles.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.